Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Freedom Bunker
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

“Your ‘Equity’ Is Fake” – Robinhood Faces Backlash After OpenAI Denounces Tokenized Shares

% of readers think this story is Fact. Add your two cents.


“Your ‘Equity’ Is Fake” – Robinhood Faces Backlash After OpenAI Denounces Tokenized Shares

Authored by Kathleen Kinder via CoinLaw.io,

OpenAI has publicly rejected Robinhood’s new “OpenAI tokens,” clarifying they do not represent actual equity in the company.

Key Takeaways

  1. OpenAI disavowed Robinhood’s tokenized equity products, stating they do not grant real ownership in OpenAI.

  2. The tokens offer indirect exposure through a Special Purpose Vehicle, not direct shares.

  3. Elon Musk and others have criticized Robinhood’s efforts as misleading.

  4. The move highlights growing tensions between crypto innovation and traditional private equity rules.

In a clash that is drawing widespread attention across finance and tech circles, OpenAI has forcefully rejected Robinhood’s latest effort to sell “OpenAI tokens” to retail investors. The controversy erupted after Robinhood announced it would distribute these tokens to European Union users, promoting them as a way for everyday people to gain exposure to private company equity using blockchain technology. While Robinhood framed the move as a step toward democratizing finance, OpenAI and key industry voices have condemned the tokens as misleading and lacking in substance.

OpenAI’s Public Statement: No Equity, No Endorsement

OpenAI, the well-known artificial intelligence company, issued a rare public statement from its official newsroom account, clearly distancing itself from Robinhood’s offering.
“These ‘OpenAI tokens’ are not OpenAI equity. We did not partner with Robinhood, were not involved in this, and do not endorse it. Any transfer of OpenAI equity requires our approval—we did not approve any transfer. Please be careful,” the company wrote on X.

OpenAI’s response was triggered by Robinhood’s announcement earlier in the week, in which the fintech platform rolled out tokenized shares of OpenAI, SpaceX, and other major private firms. These digital assets were distributed to select users in the EU as part of a promotional giveaway.

Robinhood’s Defense: Democratizing Private Assets

Robinhood’s leadership responded by defending the program, emphasizing that the tokens are designed to give retail investors indirect access to previously exclusive markets. A spokesperson for Robinhood clarified, “These tokens give retail investors indirect exposure to private markets, opening up access, and are enabled by Robinhood’s ownership stake in a special purpose vehicle.”

Robinhood CEO Vlad Tenev echoed this sentiment, stating, “While it is true that they are not technically ‘equity,’ the tokens effectively give retail investors exposure to these private assets. Our giveaway plants a seed for something much bigger, and since our announcement we have been hearing from many private companies that are eager to join us in the tokenization revolution.”

The company rolled out the tokens as part of a broader effort to introduce tokenized stocks and real-world asset trading for European customers, building on a newly launched layer two blockchain network for settling tokenized equity trades.

What Are Investors Actually Buying?

Despite Robinhood’s promotional messaging, the underlying structure of the tokens is complex and layered.

  • Investors are not purchasing actual shares of OpenAI or direct stakes in the company.

  • The tokens represent contracts linked to Robinhood’s ownership interest in an SPV, which itself holds shares of private companies.

  • This means buyers are two steps removed from actual equity, and the value of the tokens may diverge significantly from the true value of the underlying shares.

  • According to Robinhood’s help center, users buying these tokens are acquiring “tokenized contracts that follow the price” of the underlying assets, recorded on blockchain.

Industry Pushback and Criticism

The move by Robinhood has attracted strong criticism, both from within the industry and from high-profile figures.

  • Elon Musk, co-founder of OpenAI and SpaceX, took to X to call the equity claims “fake,” highlighting his broader concerns about OpenAI’s shift toward a for-profit model.
  • Industry analysts note that private companies typically guard their cap tables and limit share sales to selected investors, making Robinhood’s approach unusual and controversial.

  • In similar instances, other startups like Figure AI have sent cease-and-desist letters to brokers marketing unauthorized share sales, underlining how sensitive private companies are about third parties trading or referencing their equity.

Broader Context: Tokenization and Financial Inclusion

Robinhood’s foray into tokenized private equity reflects a larger trend in finance, where crypto exchanges and platforms seek to offer access to previously inaccessible asset classes such as private equity, private credit, and commercial real estate.

  • Traditionally, these assets are reserved for accredited investors with significant wealth or credentials, limiting opportunities for the average retail customer.
  • Robinhood argues that tokenization and asset fractionalization can help break down these barriers, though critics warn that regulatory and ethical questions remain unresolved.

CoinLaw’s Takeaway

This episode is a clear signal of the growing friction between fast-moving crypto innovation and the strict, carefully controlled world of private company finance. While Robinhood presents tokenization as a breakthrough for retail investors, OpenAI’s sharp rebuke makes it clear that not all stakeholders see it that way. Investors should scrutinize exactly what is being offered and recognize that buying a token does not always mean owning a share in the world’s biggest private companies.

Tyler Durden Thu, 07/03/2025 – 12:00


Source: https://freedombunker.com/2025/07/03/your-equity-is-fake-robinhood-faces-backlash-after-openai-denounces-tokenized-shares/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.